What is the official website of Gallus BioPharmaceuticals ?

The official website of Gallus BioPharmaceuticals is http://www.Patheon.com.

What is Gallus BioPharmaceuticals's cybersecurity risk score?

Gallus BioPharmaceuticals has an AI-generated cybersecurity risk score of 750 out of 1000, indicating a Fair security posture according to Rankiteo's assessment.

How many security incidents has Gallus BioPharmaceuticals experienced?

According to Rankiteo, Gallus BioPharmaceuticals currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has Gallus BioPharmaceuticals been affected by any supply chain cyber incidents ?

According to Rankiteo, Gallus BioPharmaceuticals has been affected by a supply chain cyber incident involving Fisher Healthcare, with the incident ID FISMIC1784032242.

Does Gallus BioPharmaceuticals have SOC 2 Type 1 certification ?

According to Rankiteo, Gallus BioPharmaceuticals is not certified under SOC 2 Type 1.

Does Gallus BioPharmaceuticals have SOC 2 Type 2 certification ?

According to Rankiteo, Gallus BioPharmaceuticals does not hold a SOC 2 Type 2 certification.

Does Gallus BioPharmaceuticals comply with GDPR ?

According to Rankiteo, Gallus BioPharmaceuticals is not listed as GDPR compliant.

Does Gallus BioPharmaceuticals have PCI DSS certification ?

According to Rankiteo, Gallus BioPharmaceuticals does not currently maintain PCI DSS compliance.

Does Gallus BioPharmaceuticals comply with HIPAA ?

According to Rankiteo, Gallus BioPharmaceuticals is not compliant with HIPAA regulations.

Does Gallus BioPharmaceuticals have ISO 27001 certification ?

According to Rankiteo,Gallus BioPharmaceuticals is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does Gallus BioPharmaceuticals operate in ?

Gallus BioPharmaceuticals operates primarily in the Biotechnology Research industry.

How many employees does Gallus BioPharmaceuticals have ?

Gallus BioPharmaceuticals employs approximately 64 people worldwide.

Does Gallus BioPharmaceuticals own any subsidiaries ?

Gallus BioPharmaceuticals presently has no subsidiaries across any sectors.

How many LinkedIn followers does Gallus BioPharmaceuticals have ?

Gallus BioPharmaceuticals's official LinkedIn profile has approximately 2,567 followers.

What is the NAICS classification code for Gallus BioPharmaceuticals ?

Gallus BioPharmaceuticals is classified under the NAICS code 541714, which corresponds to Research and Development in Biotechnology (except Nanobiotechnology).

Does Gallus BioPharmaceuticals have a Crunchbase profile ?

Yes, Gallus BioPharmaceuticals has an official profile on Crunchbase, which can be accessed here: https://www.crunchbase.com/organization/gallus-biopharmaceuticals.

Does Gallus BioPharmaceuticals have a LinkedIn profile ?

Yes, Gallus BioPharmaceuticals maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/gallus-biopharmaceuticals.

How many cybersecurity incidents has Gallus BioPharmaceuticals experienced ?

As of September 19, 2026, Rankiteo reports that Gallus BioPharmaceuticals has experienced 3 cybersecurity incidents.

How many peer or competitor companies does Gallus BioPharmaceuticals have ?

Gallus BioPharmaceuticals has an estimated 4,766 peer or competitor companies worldwide.

What types of cybersecurity incidents has Gallus BioPharmaceuticals faced ?

Incident Types: The types of cybersecurity incidents that have occurred include Breach and Vulnerability.

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

Gallus BioPharmaceuticals

Boost Score +25 with badge (5 left)

750

/1000

Fair

775

/1000

Fair

Gallus BioPharmaceuticals Vendor Cyber Rating & Cyber Score

patheon.com

cb in

Add Your Compliance Badge

September 30, 2014 - Gallus BioPharmaceuticals, LLC has been acquired by DPx Holdings B.V., privately owned by JLL Partners and Royal DSM and the parent company of Patheon. Patheon’s biologic drug substance business, a unit of DPx Holdings, now spans four global facilities in Europe, Australia and North America and includes more than 550 employees. Please visit the Patheon LinkedIn page to learn more about our expanded capabilities and to follow Patheon. Visit our website at http://www.Patheon.com

Gallus BioPharmaceuticals

Gallus BioPharmaceuticals CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

Thermo Fisher Scien...

Vulnerability

7/2026

THE1785781553

Fisher Healthcare

Breach

5/2024

Fisher Healthca...

FISMIC178403224...

Gallus BioPharmaceu...

Breach

7/2017

THE206072925

Loading…

A.I.

Gallus BioPharmaceuticals Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for Gallus BioPharmaceuticals

Incidents vs Biotechnology Research Industry Avg (This Year)

No incidents recorded for Gallus BioPharmaceuticals in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for Gallus BioPharmaceuticals in 2026.

Incident Types Gallus BioPharmaceuticals vs Biotechnology Research Industry Avg (This Year)

No incidents recorded for Gallus BioPharmaceuticals in 2026.

Incident History - Gallus BioPharmaceuticals (X = Date, Y = Severity)

Loading…

SUBSIDIARY

Gallus BioPharmaceuticals Subsidiaries

Gallus BioPharmaceuticals

Biotechnology Research

Website: http://www.Patheon.com

Company Size: 64

PatheonPharmaceutical Manufacturing

Thermo Fisher ScientificBiotechnology Research

PPDResearch Services

Accelerated Enrollment SolutionsPharmaceutical Manufacturing

PPD™ Laboratory ServicesPharmaceutical Manufacturing

EvideraResearch Services

PPD™ Biotech SolutionsPharmaceutical Manufacturing

Thermo ScientificBiotechnology Research

Accelerating MicroscopyBiotechnology

Chromatography & Mass SpectrometryBiotechnology

FEI CompanyNanotechnology Research

Unity Lab ServicesBiotechnology Research

Fisher HealthcareHospitals and Health Care

Advancing MaterialsResearch Services

Thermo Fisher Spectral CytometryBiotechnology Research

Laureate Biopharmaceutical ServicesBiotechnology Research

Laureate PharmaBiotechnology Research

Loading…

Gallus BioPharmaceuticals Similar Companies

bioMérieux

biomerieux.com

A family-owned company, bioMérieux has grown to become a world leader in the field of in vitro diagnostics. Our entrepreneurial adventure, begun over a century ago, is driven by an unrelenting commitment to improve public health worldwide. Since 1963, we've been paving the way in the field of in vitro diagnostics and have contributed greatly to improving public health and making the world a healthier place. The solutions that our teams imagine, develop and manufacture are key to enable healthcare professionals and industry players to make confident decisions to improve patient outcome and ensure consumer safety.

Syneos Health

cb syneoshealth.com

Syneos Health® is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique clinical, medical affairs and commercial insights into outcomes to address modern market realities. We bring together a talented team of professionals with a deep understanding of patient and physician behaviors and market dynamics. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. Syneos Health supports a diverse, equitable and inclusive culture that cares for colleagues, customers, patients, communities and the environment.

Charles River Laboratories

criver.com

At Charles River, we are guided by our strong purpose—to create healthier lives—which centers around the patients who rely on the therapeutics we help to develop, the animals in our care, to our planet, and to the passionate and skilled people who are at the heart of our organization and make it all possible. #DrugDiscovery #Biotech #Biotechnology #Pharmaceuticals #CRL

CSL

cb csl.com

CSL is a leading global biopharma company with a dynamic portfolio of lifesaving medicines, including those that treat haemophilia and immune deficiencies, vaccines to prevent influenza, and therapies in iron deficiency, dialysis and nephrology. Since our start in 1916, we have been driven by our promise to save lives using the latest technologies. Today, CSL – including our businesses, CSL Behring, CSL Seqirus, and CSL Vifor – provides lifesaving products to patients in more than 100 countries and employs 29,000+ people. Our unique combination of commercial strength, R&D focus and operational excellence enables us to identify, develop and deliver innovations so our patients can live life to the fullest. See our community guidelines: https://bit.ly/3Bs17Ra

ICON plc

iconplc.com

Since our foundation in Dublin, Ireland in 1990, our mission has been to help our clients to accelerate the development of drugs and devices that save lives and improve quality of life. We do this by delivering best in class information, solutions and performance, with an unyielding focus on quality at all times. We offer a full range of consulting, development and commercialisation services from a global network of offices in 53 countries. We focus our innovation on the factors that are critical to our clients – reducing time to market, reducing cost, and increasing quality – and our global team of experts has extensive experience in a broad range of therapeutic areas.

Fortrea

fortrea.com

Fortrea (Nasdaq: FTRE) is a leading global clinical research organization (CRO) dedicated to providing innovative clinical development solutions to the life sciences industry. With over 30 years of clinical research experience, Fortrea has evolved from Covance and Labcorp into a pureplay CRO built for biotech, biopharma, medical device and diagnostic innovators. Fortrea collaborates with both emerging and established companies to deliver agile, fit-for-purpose full service (FSO), functional service (FSP) and hybrid solutions. Fortrea provides comprehensive Phase I-IV clinical trial management, clinical pharmacology, and consulting services, backed by deep experience in more than 20 therapeutic areas. Operating in approximately 100 countries, our diverse and talented team brings scientific rigor, operational excellence, and a strong investigator site network to every trial. By combining the best of our legacy experience with forward-thinking innovation, Fortrea brings predictability to clinical trial execution and helps transform aspirations into outcomes. Together, exceptional is possible. Learn more at Fortrea.com

The National Institutes of Health

cb nih.gov

NIH is the only agency of its kind. We impact the health of the country and the world through unique and innovative medical research. Did you know that NIH is the largest public funder of biomedical research in the world, investing more than $32 billion a year to enhance life, and reduce illness and disability? NIH funded research has led to breakthroughs and new treatments, helping people live longer, healthier lives, and building the research foundation that drives discovery. Whether you are graduating with a bachelor's degree, working on your doctoral degree, entering the workforce for the first time, or changing careers, NIH offers a place for you to start and plenty of room to grow your career. When you join us, you’re not just advancing your career — you’re driving the health of our country forward. Official LinkedIn Account of the NIH. Privacy policy: http://go.usa.gov/x9svN Comment policy: https://bit.ly/3G6xq94 Engagement ≠ endorsement

Genentech

gene.com

About Genentech We're passionate about finding solutions for people facing the world's most difficult-to-treat conditions. That is why we use cutting-edge science to create and deliver innovative medicines around the globe. To us, science is personal. Making a difference in the lives of millions starts when you make a change in yours. If you’d like to join our team, view our openings at gene.com/careers. Our patient resource center is dedicated to getting patients and caregivers to the right resources. You can reach them at 1 (877) GENENTECH (436-3683) Monday-Friday, 6am-5pm PST or [email protected]. Community Guidelines: 1. We want to foster positive conversation around the issues we are passionate about. To that end, we remove profanity, content that contains threatening language, content that is aimed at private individuals, personal information, and repeated unwanted messages. 2. Don’t mention any medicines by name — ours or anyone else’s. Because of the fair balance rules governing our industry, we cannot post any comments that reference any pharmaceutical brand, product, or service. Please do not mention any specific medicines by name, or include any links to third party sites in your comments. 3. This isn’t the place to report or discuss side effects. This site is not intended as a forum for reporting side effects experienced while taking a Genentech product. Instead, you should report any side effects to Genentech Drug Safety at 1-888-835-2555. You can also report side effects of any prescription product directly to the FDA at 1-800-FDA-1088 or by visiting www.FDA.gov/medwatch. 4. Don’t pitch your product or service. Please don't use our page as a place to promote your product or pitch your services. Please also avoid posting links to external sites. We reserve the right to remove any posts that are deemed promotional.

Gilead Sciences

cb gilead.com

At Gilead, we set – and achieve – bold ambitions to create a healthier world for all people. From our pioneering virology medicines to our growing impact in oncology, we're delivering innovations once thought impossible in medicine. Our focus goes beyond medicines, and we also strive to remedy health inequities and break down barriers to care. We empower our people to tackle these challenges, and we’re all united in our commitment to help millions of people live healthier lives. Social Media Guidelines: https://www.gilead.com/social-media-guidelines

Loading…

NEWS

Gallus BioPharmaceuticals CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-93740

SUMMARY

A vulnerability was identified in Totolink A3002MU Hh-B20211125.1046. Affected is the function formWlEncrypt of the file /boafrm/formWlEncrypt. The manipulation of the argument submit-url leads to buffer overflow. It is possible to initiate the attack remotely. The exploit is publicly available and might be used.

Published

Date2026-09-18

Updated

Date2026-09-18

RISK INFORMATION (Score: 10)

cvss2

Base Score: 10.0

Complexity: LOW

AV:N/AC:L/Au:N/C:C/I:C/A:C

cvss3

Base Score: 10.0

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:C/C:H/I:H/A:H

cvss4

Base Score: 9.3

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:H/VI:H/VA:H/SC:H/SI:H/SA:H/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

Exploitability

3.9

REFERENCES

CVE-2026-93739

SUMMARY

A vulnerability was determined in Totolink A3002MU Hh-B20211125.1046. This impacts the function formWlAc of the file /boafrm/formWlAc. Executing a manipulation of the argument submit-url can lead to buffer overflow. The attack may be performed from remote. The exploit has been publicly disclosed and may be utilized.

Published

Date2026-09-18

Updated

Date2026-09-18

RISK INFORMATION (Score: 9.9)

cvss2

Base Score: 9.0

Complexity: LOW

AV:N/AC:L/Au:S/C:C/I:C/A:C

cvss3

Base Score: 9.9

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:H/I:H/A:H

cvss4

Base Score: 8.6

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:H/VA:H/SC:H/SI:H/SA:H/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

Exploitability

3.1

REFERENCES

CVE-2026-75885

SUMMARY

A flaw was found in the OpenShift console. Unauthenticated access to the `/api/devfile/` and `/api/devfile/samples/` endpoints allows a remote attacker to send crafted devfile payloads. This can lead to Server-Side Request Forgery (SSRF), where the console pod makes requests to internal services and reflects partial responses to the attacker. Additionally, by sending repeated large requests without a specified content length, an attacker can cause unbounded memory growth, leading to a Denial of Service (DoS).

Published

Date2026-09-18

Updated

Date2026-09-18

RISK INFORMATION (Score: 9.3)

cvss3

Base Score: 9.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:C/C:H/I:N/A:L

Impact Score

4.7

Exploitability

3.9

REFERENCES

CVE-2026-93894

SUMMARY

In Vinyl Cache before 9.0,2, workspace buffer overflow vulnerability was found in the .upper() and .lower() string type methods of VCL. This can be used as a remote denial of service (DoS) vector to make the child process segfault or assert, and then restart. Effectively exploiting this vulnerability requires prior knowledge about the VCL in use and the ability to craft a request that contains a string that is long enough to fill the remaining workspace at the call site while staying under the different request size limits (http_req_size, http_req_hdr_len, etc.).

Published

Date2026-09-18

Updated

Date2026-09-18

RISK INFORMATION (Score: )

cvss4

Base Score: 2.3

Complexity: HIGH

CVSS:4.0/AV:N/AC:H/AT:P/PR:L/UI:N/VC:N/VI:N/VA:L/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:N/R:A/V:D/RE:L/U:Clear

Impact Score

Exploitability

REFERENCES

https://vinyl-cache.org/security/VSV00020.html

CVE-2026-93738

SUMMARY

A vulnerability was found in Totolink A3002MU Hh-B20211125.1046. This affects the function formSchedule of the file /boafrm/formSchedule. Performing a manipulation of the argument webpage results in buffer overflow. The attack is possible to be carried out remotely. The exploit has been made public and could be used.

Published

Date2026-09-18

Updated

Date2026-09-18

RISK INFORMATION (Score: 9.9)

cvss2

Base Score: 9.0

Complexity: LOW

AV:N/AC:L/Au:S/C:C/I:C/A:C

cvss3

Base Score: 9.9

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:H/I:H/A:H

cvss4

Base Score: 8.6

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:H/VA:H/SC:H/SI:H/SA:H/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

Exploitability

3.1

REFERENCES

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…

Badge your company to reduce your risk score and your cyber insurance costs!

Trusted by insurers. Chosen by leaders.

Gallus BioPharmaceuticals Vendor Cyber Rating & Cyber Score

Gallus BioPharmaceuticals A.I CyberSecurity Scoring

Gallus BioPharmaceuticals CyberSecurity News & History

Gallus BioPharmaceuticals Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Incident Predictions locked

A.I Risk Score Likelihood 3 - 6 - 9 months

A.I. Risk Score Predictions locked

Underwriter Stats for Gallus BioPharmaceuticals

Incidents vs Biotechnology Research Industry Avg (This Year)

Incidents vs All-Companies Average (This Year)

Incident Types Gallus BioPharmaceuticals vs Biotechnology Research Industry Avg (This Year)

Incident History - Gallus BioPharmaceuticals (X = Date, Y = Severity)

Gallus BioPharmaceuticals Subsidiaries

Gallus BioPharmaceuticals

Gallus BioPharmaceuticals Similar Companies

bioMérieux

Syneos Health

Charles River Laboratories

CSL

ICON plc

Fortrea

The National Institutes of Health

Genentech

Gilead Sciences

Gallus BioPharmaceuticals CyberSecurity News

Global CVEs (Not Company-Specific)

Access Data Using Our API

What Do We Measure ?

These are some of the factors we use to calculate the overall score:

Rankiteo

Gallus BioPharmaceuticals CyberSecurity News & History

Gallus BioPharmaceuticals Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Incident Predictions locked

A.I Risk Score Likelihood 3 - 6 - 9 months

A.I. Risk Score Predictions locked

Underwriter Stats for Gallus BioPharmaceuticals

Incidents vs Biotechnology Research Industry Avg (This Year)

Incidents vs All-Companies Average (This Year)

Incident Types Gallus BioPharmaceuticals vs Biotechnology Research Industry Avg (This Year)

Incident History - Gallus BioPharmaceuticals (X = Date, Y = Severity)

Gallus BioPharmaceuticals Subsidiaries

Gallus BioPharmaceuticals

Gallus BioPharmaceuticals Similar Companies

bioMérieux

Syneos Health

Charles River Laboratories

CSL

ICON plc

Fortrea

The National Institutes of Health

Genentech

Gilead Sciences

Gallus BioPharmaceuticals CyberSecurity News

Global CVEs (Not Company-Specific)

Access Data Using Our API

What Do We Measure ?

These are some of the factors we use to calculate the overall score:

Rankiteo